The Effect of Prognostıc Factors and Potentıal Treatment Regımens on Fatality Covid-19 Patıents

  • Ahmet Doğan Department of Infection Diseases and Clinical Microbiology, Ordu State Hospital, Ordu, Turkey
  • Hatun Öztürk Çerik Department of Infection Diseases and Clinical Microbiology, Ordu State Hospital, Ordu, Turkey
  • Atila Gürgen Department of Mental Health and Diseases, Ordu State Hospital, Ordu, Turkey
  • Aykut Özturan Department of Internal Medicine, Ordu State Hospital, Ordu, Turkey
Keywords: Prognostic Factors, Covid-19, Fatality, Neutrophil Lymphocyte Ratio

Abstract

The ongoing outbreak of the coronavirus disease 2019 (COVID-19), as named by the World Health Organization, has millions of confirmed cases worldwide and has claimed hundreds of thousands of lives. The virus was named SARS-CoV-2 in February by the International Committee on Taxonomy of Viruses. COVID-19 presents as fever, dry cough, dyspnea, headache, and pneumonia. In a small subset of severe cases, the disease quickly progresses to respiratory failure and even death. This study aimed to know the effects of clinical and laboratory features on investigated death. The diagnosis was based on typical findings in thoracic computed tomography (CT) and positive results of the Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) SARS-CoV-2. The demographic characteristics of COVID-19 patients treated, accompanying comorbid conditions and laboratory criteria (blood lymphocyte counts, C Reactive Protein (CRP), D-dimer, Interleukin 6 (IL-6), blood neutrophil count/lymphocyte counts) were collected retrospectively. The results show that 121 cases, 66 (54.54%) were male, 55 (45.46%) were female, and the mean age was ± Std (Min-Max), 59.63 ± 17.4 (22-91). Neutrophil percentage (p = 0.027), neutrophil / lymphocyte ratio (NE / LE) (p = 0.028), CRP (p = <0.001), PCT (p = 0.004), D dimer (p = 0.021) and IL 6 (p = 0.047) in patients with a fatal course, higher values were found than those recovered. Blood lymphocyte count (p = 0.001) and percent (p <0.001) were lower. Number of blood white spheres (p = 0.010), blood neutrophil counts (p = 0.001) and percentage (p <0.001), NE / LE (p0.001), CRP (p <0.001), PCT (p = 0.003) and IL -6 (p <0.001) levels were higher in patients with severe clinical findings than in mild cases. The case death rate was observed as 9%. Covid-19 patients should consider blood neutrophil percentage, blood lymphocyte count, blood lymphocyte percentage, NE / LE, CRP, D dimer, and IL 6 values as an early warning in terms of prognosis. More experience was needed to assess the benefits of immune plasma, tocilizumab, IVIG treatments, and remdesivir therapy recently introduced to the treatment protocol.

Downloads

Download data is not yet available.

References

Ai, T., Yang, Z., Hou, H., Zhan, C., Chen, C., Lv, W., Tao Q, Sun Z, & Xia, L. (2020). Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology, 296(2), E-32-E40. DOI: 10.1148/radiol.2020200642

Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020). Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. Jama, 323(16), 1612-1614. DOI: 10.1001/jama.2020.4326

Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, evaluation and treatment coronavirus (COVID-19). In Statpearls [internet]. Stat Pearls Publishing.

Chan, K. S., Lai, S. T., Chu, C. M., Tsui, E., Tam, C. Y., Wong, M. M. L., ... & Wong, V. C. W. (2003). Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Medical Journal, 9: 399-406.

Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., ... & Mulders, D. G. (2020). Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance, 25(3), 270-280. DOI:10.2807/1560-7917.ES.2020.25.3.2000045

Fang, Y., Zhang, H., Xie, J., Lin, M., Ying, L., Pang, P., & Ji, W. (2020). Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology, 296(2),E-115-E117. DOI: 10.1148/radiol.2020200432

Gao, Y., Li, T., Han, M., Li, X., Wu, D., Xu, Y., ... & Wang, L. (2020). Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19. Journal of medical virology.92, 791-796. DOI:10.1002/jmv.25770

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497-506. DOI: 10.1016/S0140-6736(20)30183-5

Ji, Y., Ma, Z., Peppelenbosch, M. P., & Pan, Q. (2020). Potential association between COVID-19 mortality and health-care resource availability. The Lancet. Global health, 8(4), e480. DOI: 10.1016/S2214-109X (20)30068-1

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., ... & Xing, X. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine, 382:1199–1207. DOI: 10.1056/NEJMoa2001316

Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., ... & Bi, Y. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, 395(10224), 565-574. DOI: 10.1016/S0140-6736(20)30251-8

Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., ... & Miao, X. (2020). Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurology, 77(6), 683-690. DOI: 10.1101/2020.02.22.20026500.

Mardani, R., Vasmehjani, A. A., Zali, F., Gholami, A., Nasab, S. D. M., Kaghazian, H., ... & Ahmadi, N. (2020). Laboratory parameters in detection of COVID-19 patients with positive RT-PCR; a diagnostic accuracy study. Archives of Academic Emergency Medicine, 8(1), E-43.

Moutchia, J., Pokharel, P., Kerri, A., McGaw, K., Uchai, S., Nji, M., & Goodman, M. (2020). Clinical Laboratory Parameters Associated with Severe or Critical Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-analysis. medRxiv. DOI: 10.1101/2020.04.24.20078782

Nebraska Medicine (2020). COVID-19 Antiviral and pharmacotherapy recommendations. Nebraska Medicine

The Republic of Turkey Ministry of Health. (2020). COVID-19 Weekly Situation Report, 29/06/2020–05/07/2020, Turkey. The Republic of Turkey Ministry of Health

The Republic of Ministry of Health, General Directorate of Public Health. (2020). Covid-19 (SARS-CoV-2 Infection), Adult Patient Treatment, Scientific Advisory Board Study, August 2, 2020. The Republic of Ministry of Health, General Directorate of Public Health

Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., ... & Huang, X. (2020). Clinical features and treatment of COVID‐19 patients in northeast Chongqing. Journal of medical virology. DOI: 10.1002/jmv.25783.

Wang D, Hu B, Hu C, Zhu, F., Liu, X., Zhang J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020, 323 (11):1061–1069. DOI: 10.1001/jama.2020.1585

Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. (2020). Detection of SARS-CoV-2 in different types of clinical specimens. Jama, 323(18), 1843-1844. DOI: 10.1001/jama.2020.3786

Wax, R. S., & Christian, M. D. (2020). Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can J Anesth/J Can Anesth 67, 568–576 . DOI: 10.1007/s12630-020-01591-x

WHO. (2020). Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). World Health Organization.

WHO. (2020). Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020. World Health Organization.WHO. (2020). WHO statement regarding a cluster of pneumonia cases in Wuhan, China?. World Health Organization.

Yang, A. P., Liu, J., Tao, W., & Li, H. M. (2020). The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International immunopharmacology, 84, 106504. DOI: 10.1016/j.intimp.2020.106504

Yang, X., Yu, Y., Xu, J., Shu, H., Liu, H., Wu, Y., ... & Wang, Y. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. DOI: 10.1016/S2213-2600(20)30079-5

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., ... & Guan, L. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet, 395 (10229): 1054-1062. DOI: 10.1016/S0140-6736(20)30566-3

Published
2020-12-31
How to Cite
Doğan, A., Çerik, H. Öztürk, Gürgen, A., & Özturan, A. (2020). The Effect of Prognostıc Factors and Potentıal Treatment Regımens on Fatality Covid-19 Patıents. JURNAL INFO KESEHATAN, 18(2), 113-127. https://doi.org/10.31965/infokes.Vol18.Iss2.445
Abstract viewed = 90 times
PDF downloaded = 21 times